A Systematic Review of Autoimmune Oophoritis Therapies

• Published in: Reproductive sciences (Thousand Oaks, Calif.) Calif.), 2024, Vol.31 (1), p.1-16
• Main Authors: Levit, Elizabeth, Singh, Bhuchitra, Nylander, Elisabeth, Segars, James H.
• Format: Article
• Language: English
• Subjects: Animals; Autoimmune Diseases - complications; Autoimmune Diseases - drug therapy; Embryology; Female; Fertilization in Vitro - methods; Humans; Infertility, Female - etiology; Live Birth; Medicine; Medicine & Public Health; Obstetrics/Perinatology/Midwifery; Oophoritis; Polyendocrinopathies, Autoimmune - complications; Pregnancy; Pregnancy Rate; Reproductive Endocrinology: Review; Reproductive Medicine; Reproductive Techniques, Assisted - adverse effects
• ISSN: 1933-7191; 1933-7205; 1933-7205
• DOI: 10.1007/s43032-023-01299-5

Autoimmune primary ovarian insufficiency (POI) is a devastating disease with limited clinical guidance. The objective of this systematic review was to identify treatments for autoimmune POI and analyze their efficacy. A comprehensive search of CINAHL, Cochrane, Embase, PubMed, Scopus, and Web of Science was performed from inception to April 2022. English language publications that evaluated women with autoimmune POI after a documented intervention were included. Animal models of autoimmune POI were also included. Risk of bias was assessed with the SYRCLE’s risk of bias tool for animal studies or the NIH Quality Assessment Tool for Case Series as appropriate. Twenty-eight studies were included in this review, with 11 RCTs, 15 case reports, and 2 case series. Seventeen studies were in humans, and 11 were in animal models. No completed RCTs, cohort studies, or case-control studies were identified in humans. In observational human studies, corticosteroids were effective in select patients. In many case reports, adequate treatment of comorbid autoimmune conditions resulted in return of menses, hormonal normalization, or spontaneous pregnancy. In terms of assisted reproductive technologies, there was case report evidence for both in vitro fertilization (IVF) and in vitro maturation (IVM) in women wishing to conceive with their own oocytes. Ovulation induction, IVF, and IVM resulted in a total of 15 pregnancies and 14 live births. In animal models, there was additional evidence for stem cell therapies and treatments used in traditional Chinese medicine, although this research may not be generalizable to humans. Furthermore, litter size was not evaluated in any of the animal studies. Additional research is needed to establish the efficacy of current treatments for autoimmune POI with a controlled experimental design and larger sample size. Additionally, there is a critical need to develop novel therapies for this condition, as understanding of its pathophysiology and  available tools to modulate the immune response have progressed.